Pre-market we see PATH stock at $11.57 on the NYSE in the United States on 17 Mar 2026. That price tracks a 50-day average of $13.10 and a 200-day average of $13.42, while volume is elevated at 38,790,185 shares. UiPath Inc. (PATH) reported a recent quarter with EPS $0.42 and a trailing PE near 27.56, leaving investors balancing AI-driven margin gains against tempered full-year guidance.
PATH stock quick snapshot and market context
UiPath Inc. (PATH) opened pre-market at $11.57 on the NYSE in the United States. The stock range today is $11.47–$11.88, with a 52-week high of $19.84 and low of $9.38.
Market cap sits near $6.19 billion, average volume is 34,020,615, and the company trades with a beta of 1.09. See price data and headlines at MarketWatch.
PATH stock fundamentals and earnings context
UiPath reported the last quarter with revenue $481.11 million, EPS $0.30 (beat by $0.05), and reported ARR near $1.85 billion, showing platform traction on agentic AI initiatives. Gross margin was reported near 86%, and net margin is about 17.53%, underscoring high software economics.
On valuation, trailing PE is 27.56, price-to-sales is 3.85, current ratio 2.48, and free cash flow yield is 5.67%. Those ratios place PATH stock in the mid-range among Software – Infrastructure peers given its growth profile.
PATH stock technicals and trading signals
Technical indicators show RSI 47.86, MACD histogram 0.22, and ADX 24.17, signaling neutral momentum with no clear trend bias. The 50-day MA $13.10 and 200-day MA $13.42 sit above the current price, which suggests short-term resistance on rallies.
Volume today at 38,790,185 exceeds the average of 34,020,615, implying higher trading interest after recent earnings and guidance commentary. Bollinger bands middle at $11.12 and ATR $0.75 indicate moderate volatility.
PATH stock analyst sentiment and investor activity
Analyst consensus leans toward Hold with three Buys, twelve Holds, and one Sell and a consensus target around $14.27. Recent broker notes showed mixed reactions: several firms trimmed targets after tempered FY guidance despite the quarter beat.
Institutional activity shows buying by funds such as Invenomic and Algert Global, while insiders sold shares this year. See institutional filings referenced at MarketBeat.
Meyka AI grade, valuation view and PATH stock forecast
Meyka AI rates PATH with a score out of 100: 77.91 (B+) — SUGGESTION: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects monthly $10.61, quarterly $11.48, and yearly $13.83. Compared with the current price $11.57, the yearly projection implies an upside of 19.54%, while the monthly view implies a downside of -8.30%. Forecasts are model-based projections and not guarantees.
PATH stock risks and catalysts for AI investors
Near-term catalysts include agentic AI platform adoption, the Deloitte partnership, and buyback programs that support earnings per share. Management completed a roughly $1.00 billion repurchase and authorized $500.00 million more, which can support shareholder returns.
Key risks are slower FY revenue growth guidance (management implied ~10% top-line growth), customer retention questions, and execution timing for AI automation to translate into faster ARR expansion. Those risks explain mixed analyst reactions and price volatility.
Final Thoughts
Key takeaway: PATH stock trades at $11.57 pre-market on 17 Mar 2026 as investors weigh strong quarterly margins and EPS beats against a tempered full-year growth guide. UiPath’s agentic AI platform and a recent buyback program improve the mix of growth and capital returns, while analyst sentiment remains mixed and insider selling continues. Meyka AI’s forecast model projects a one-year price of $13.83, implying 19.54% upside from today’s price, but the model also shows shorter-term downside to $10.61. Our view is that PATH stock is a data-driven AI play with attractive margins and a B+ Meyka grade, yet it carries execution and guidance risk. Investors should watch ARR expansion, retention metrics, and next earnings on 28 May 2026 to validate the AI adoption thesis. For a quick reference, see UiPath PATH coverage on Meyka AI’s platform at UiPath PATH at Meyka. Forecasts are model-based projections and not guarantees.
FAQs
What is the current price and valuation of PATH stock?
PATH stock is trading pre-market at $11.57 on the NYSE. Trailing PE is 27.56, price-to-sales around 3.85, and market cap about $6.19 billion. These factors position PATH as a mid-valued software name with strong gross margins.
What does Meyka AI forecast for PATH stock?
Meyka AI’s forecast model projects yearly $13.83 for PATH stock, implying 19.54% upside from $11.57. The model also shows a monthly view at $10.61. Forecasts are projections and not guarantees.
What are the main catalysts for PATH stock in 2026?
Primary catalysts include agentic AI platform adoption, enterprise ARR growth, expanded partnerships such as with Deloitte, and share buybacks. Positive surprises on retention or faster ARR expansion would likely lift PATH stock.
What are the key risks for PATH stock investors?
Key risks for PATH stock are slower full-year revenue guidance (management implied roughly 10% growth), customer retention and adoption pacing, analyst downgrades, and continued insider selling. Execution on AI monetization is crucial.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)